U.S. Consultancy Work (for ACJ & Associates)

2002- Partner of Oak Ridge Associated Universities (ORAU) in the CDC/NIOSH Office of Compensation Analysis & Support’s (OCAS) Radiation Dose Reconstruction and Related Services Contract in support of EEOICPA, 2000.

2002-03 Contractor to the CANDU Owners Group (COG), Toronto, Ontario, Canada for the development of IMBA Expert™ CANDU-Edition, a suite of “expert” software for bioassay analysis and dose assessment in the operation of CANDU reactors.

2002-04 Contractor to CDC/NIOSH Office of Compensation Analysis & Support (OCAS) for the development of IMBA Expert™ OCAS-Edition, a suite of “expert” software for bioassay analysis and dose assessment to be used to carry out all internal dose assessments in support of the Energy Employees Occupational Illness Compensation Program Act (EEOICPA, 2000).

2001-04 Contractor to U.S. Department of Energy, Office of Worker Protection Programs and Hazards Management (EH-52), for the development of IMBA Expert™ USDOE-Edition (Phase I & II), suites of “expert” software for bioassay analysis and dose assessment, to be used by all USDOE sites.

2001 Consultant to Washington State University, U.S. Transuranium and Uranium Registries to analyze and prepare for publication a whole-body donation case of a worker who had been exposed by inhalation to a finely divided aerosol of 238PuO2 ceramic particles.

2001 Consultant to CDC/NIOSH regarding dose reconstruction regulations and guidelines and evaluation of software for estimating internal doses from bioassay data with reference to Nuclear Worker Compensation.

2001 Contractor to the UK Ministry of Defence (MOD) Defence Science and Technology Laboratory (Dstl, Porton Down, UK), for the development of IMBA-URAN - MOD/Dstl Edition, a suite of “expert” software for bioassay analysis and dose assessment for natural, depleted, and enriched uranium mixtures.

2001 Contractor to Framatome ANP, Richland, WA for the development of IMBA-URAN Framatome ANP Edition, a suite of “expert” software for bioassay analysis and dose assessment in a uranium fuel fabrication plant.

2001 Contractor to Cameco Corporation, Saskatoon, Saskatchewan, Canada, for the development of IMBA-URAN Cameco-Edition, a suite of “expert” software for bioassay analysis and dose assessment in the uranium mining and milling industry.

2001 Contractor to the U.S. Environmental Protection Agency, Office of Radiation and Indoor Air (ORIA) for comparative dosimetry following the BEIR VI Report.

2000 Consultant to a private client concerning natural radionuclides in building products.

2000 Scientific expert for General Electric providing advice on flawed testimony of Plaintiff’s expert in Tokerud vs PG&E et al. Defendants were awarded Summary Judgement.

2000 Consultant to Cameco Corporation, Saskatoon, Saskatchewan, Canada for development of software to resolve multiple particle-size distribution components in workplace measurements of airborne uranium aerosols made with personal cascade impactors.

1999 Consultant to WAUSAU Insurance Companies and The Travelers Insurance on potential radiation exposure of an underground miner working in the Cannikin shaft and device cavity on Amchitka Island, Alaska.

1999 Consultant to the Pacific Northwest National Laboratory, Richland, WA on radiological protection issues concerning exposure to radon and its progeny at the Fernald plant, Ohio.

1999 Consultant to Westlakes Scientific Consulting Ltd., Whitehaven, Cumbria, UK on tissue dosimetry (absorbed fractions for alpha, beta, and photon emissions) for ingested natural alpha emitters in the esophagus.

1998-89 Consultant to Pacific Gas & Electric on radiation exposure and dose potentially received by a worker at the Vallecitos experimental reactor facilities, Pleasanton, CA.

1998 Consultant to American Nuclear Insurers and expert witness, concerning radiation doses allegedly received by Plaintiffs from discharges of airborne uranium from the Apollo fuel fabrication plant, Apollo, PA (in litigation of Hall et al. v. Babcock & Wilcox et al.).

1998 Consultant to U.S. Department of Energy, Richland Operations Office, to provide independent review of internal dose conversion coefficients incorporated in the Hanford Tank Waste Remediation System (TWRS) FSAR for evaluating radiological consequences of potential TWRS accidents. Contributed to Tier II Review Safety Evaluation Report (TWRS-RT-SER-03).

1997- Consultant to Boeing North America, Inc., on class action litigation involving the Comprehensive Environmental Response Compensation and Liability ACT (CERCLA) in relation to the Rocketdyne Facilities in Simi Hills, Canoga Park, and San Fernando Valley, California.

1997 Internal dosimetry consultant for the Dow Chemical Company in the United States District Court, District of Colorado Case of Merilyn Cook et al., v. Rockwell International Corporation and the Dow Chemical Company concerning the Plaintiffs’ class action claim for property damage allegedly resulting from plutonium released from the Rocky Flats Plant, Colorado.

1997 Internal dosimetry consultant for Northwest Electricity Board plc (UK) and The National Grid Company plc (UK) on the subject of bone marrow dose in relation to exposure to radon daughters, and the magnitude of any enhancement that could occur in the presence of a high external electromagnetic field (in Studholme v. NORWEB plc and Loxton v. The National Grid Company plc).

1997 Consultant to The Sapphire Group, Inc., Bethesda, Maryland, on the modeling of lung tissue burdens from exposure to environmental tobacco smoke in workplaces.

1997 Internal dosimetry consultant to Rio Tinto, plc (UK) on the subject of exposure of a uranium miner in relation to causation of laryngeal cancer.

1997 Consultant to the Australian Radiation Laboratory to implement ICRP’s recycling metabolic models in LUDEP vs. 3.0.

1997 Consultant to the Pacific Northwest National Laboratory, Richland, WA and the U.S. Department of Energy Operations Office, Albuquerque, New Mexico, on revision of the Derived Investigation Level (DIL) for uranium excretion in urine for the protection of workers at Uranium Mine Tailings Remedial Action Project (UMTRA) facilities.

1997 Consultant to British Nuclear Fuels plc (UK), on the subject of dose to unborn children in Ireland resulting from past discharges of radioactive materials into the Irish Sea from the Sellafield reprocessing Plant (in Short and others v BNFL and others).

1996 Consultant to Tom H. Foulds and Associated Counsel, Hanford Litigation Office, Seattle, WA on “Radiation Doses from Exposure of the Population Surrounding the Hanford Reservation to Plutonium Released to the Atmosphere.”

1996 Consultant to the National Research Council/National Academy of Sciences Committee on Biological Effects of Ionizing Radiation (BEIR VI) on doses to lung cells from radon and its progeny.

1996-99 Consultant to the U.S. Environmental Protection Agency (EPA), National Center for Environmental Assessment, Research Triangle Park, NC to review and revise the current modeling approach used in the U.S. EPA’s Reference Concentration (RFC) methods to calculate a regional deposited dose ratio (RDDR) as a dosimetry adjustment for interspecies extrapolation of toxicology findings from the five common laboratory animal species (rat, mouse, hamster, guinea pig, and rabbit) to the human.

1996-98 Internal dosimetry consultant for Southern California Edison, San Diego Gas and Electric, and Combustion Engineering, Inc., in the case of Kennedy v. Southern California Edison, et al., in the United States District Court, Southern District of California concerning a claimed exposure of the late Mrs. Kennedy at home to fuel “flea” material released from the San Onofre Nuclear Generating Station (S.O.N.G.S), and claimed causation of her fatal leukemia.

1995-96 Consultant to the U.S. Environmental Protection Agency (EPA), National Center for Environmental Assessment, Research Triangle Park, NC on revising and finalizing the EPA document, Air Quality Criteria for Particulate Matter (PM AQCD), based on comments received from the Agency’s Clean Air Scientific Advisory Committee (CASAC) and from the public.

1995-96 Delegated U.S. expert for the U.S. Nuclear Regulatory Commission/Commission of the European Communities (USNRC/CEC) study of “Uncertainties in Radiological Consequences.”

1995 Internal dosimetry consultant and expert witness for Southern California Edison, San Diego Gas and Electric, and Combustion Engineering, Inc., in the case brought by Glen and Doreth James in the United States District Court, Southern District of California concerning a claimed exposure of Mr. James to fuel “flea” particles at the San Onofre Nuclear Generating Station (S.O.N.G.S), and claimed causation of his chronic myelogenous leukemia (CML).

1995 Consultant to the Florida Institute of Phosphate Research regarding doses and risks from proposed uses of waste product phosphogypsum (PG).